Cargando…
Inhibitory effect of theaflavin-3,3′-digallate can involve its binding to the “stem” domain of α-hemolysin of Staphylococcus aureus
Infections caused by Staphylococcus aureus are currently a worldwide threat affecting millions of individuals. The pathogenicity of S. aureus is associated with numerous virulence factors, including cell surface proteins, polysaccharides, and secreted toxins. The pore-forming α-hemolysin, known as α...
Autores principales: | Goc, Anna, Sumera, Waldemar, Rath, Matthias, Niedzwiecki, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Akadémiai Kiadó
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668921/ https://www.ncbi.nlm.nih.gov/pubmed/37856196 http://dx.doi.org/10.1556/1886.2023.00032 |
Ejemplares similares
-
Inhibition of α-hemolysin activity of Staphylococcus aureus by theaflavin 3,3’-digallate
por: Goc, Anna, et al.
Publicado: (2023) -
Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3′-digallate
por: Yussof, Ayuni, et al.
Publicado: (2022) -
Identification of Theaflavin-3,3’-Digallate as a Novel Zika Virus Protease Inhibitor
por: Cui, Xiangling, et al.
Publicado: (2020) -
Pre-treated theaflavin-3,3′-digallate has a higher inhibitory effect on the HCT116 cell line
por: Ding, Yangping, et al.
Publicado: (2017) -
Microbial Metabolism of Theaflavin-3,3′-digallate
and Its Gut Microbiota Composition Modulatory Effects
por: Liu, Zhibin, et al.
Publicado: (2020)